Talking Tumors: Evaluating Early-Stage Breast Cancer Cases in the COVID-19 Era
In our exclusive interview, Dr. Meisel and Dr. Hamilton provided insight on key data from the 2020 ASCO Virtual Scientific Program and best practices in managing patients during the coronavirus disease 2019 pandemic.
Welcome to a very special edition of OncLive® On Air! I’m your host today, Caroline Seymour.
OncLive® On Air is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.
Today, we had the pleasure of speaking with Jane L. Meisel, MD, an assistant professor in the Department of Hematology and Medical Oncology and Department of Gynecology & Obstetrics, at Winship Cancer Institute of Emory University School of Medicine, and Erika P. Hamilton, MD, director of the Breast Cancer and Gynecologic Research Program and principal investigator at Sarah Cannon Research Institute, to discuss clinical cases in early-stage breast cancer.
In our exclusive interview, Dr. Meisel and Dr. Hamilton provided insight on key data from the 2020 ASCO Virtual Scientific Program and best practices in managing patients during the coronavirus disease 2019 pandemic.
